iGenome
What makes iGenome® testing so crucial?
By analyzing the full genome, the iGenome® gene test improves the likelihood of identifying hereditary disorders. It seeks to identify variations in less well-mapped genomic regions as well as variations in genes linked to well-established hereditary disorders. It identifies alterations even in regions of the genome that do not code for proteins, in contrast to more focused methods. It provides improved diagnostic performance by more accurately identifying genomic area deletions and duplications. As a result, it can help explain phenotypes that are still undetected even after using current diagnostic methods. Last but not least, the test is very helpful when it comes to prenatal screening to stop the inheritance of dangerous and perhaps fatal genetic traits. When is the Whole Genome Sequencing (iGenome®) test advised for diagnosis? • Although there is no obvious link to a particular condition for which a genetic test that targets a specific gene is clinically available, phenotypic data or family history strongly point to a genetic explanation.
- Despite having a known genetic condition, a patient exhibits a high level of genetic counseling: Why it matters both before and after the exam It is advised that a clinical geneticist or genetic counselor provide pre- and post-test genetic counseling in order to better understand the results and to explain the potential and constraints of genetic testing.
genetic heterogeneity , which makes it more feasible to analyze several genes at once using Whole Genome Sequencing (WGS).
A patient exhibits a potential genetic condition, but a diagnosis has not been made based on the application of particular genetic tests for this phenotype.
A child who may have had a genetic illness for which the diagnosis was unclear despite the availability of targeted sequencing tests and other genetic studies.
When is the Whole Genome Sequencing (iGenome®) test advised for prevention?
- Screening of carriers: To find people or couples that have one copy of a genetic mutation for a particular recessive illness, whole genome sequencing can be utilized for carrier screening. Making family planning decisions and preventing the transmission of genetic illnesses to children can both benefit greatly from this knowledge.
- Presymptomatic screening for dominant diseases in people who are about to become parents
- Asymptomatic people who want to determine their risk of contracting a hereditary disease by taking the iGenome test.
Technical details
Next-Generation Sequencing (NGS) is a specialist technique used in the iGenome® test. A sample of the patient’s blood or saliva is used to obtain a DNA sample. In order to determine whether the patient’s DNA differs from the reference DNA, the patient’s DNA is then compared to a reference sample, which is a sample that represents the “normal” sequence of human DNA. Your doctor and skilled laboratory geneticists review any discrepancies that are discovered. Two EDTA vials are needed for the blood test.
- In four months, the results will be available.
- Blood from the patient is needed in two EDTA vials.
- Please get in touch with Scipharm customer support for information on cost coverage and related matters.
Our Customer Service Team is dedicated to responding to your inquiries about Genekor’s services. Please get in touch with us directly if you would like to order any of the tests that we offer.
